GB1307100A - Erythromycyl b amine - Google Patents
Erythromycyl b amineInfo
- Publication number
- GB1307100A GB1307100A GB5535570A GB5535570A GB1307100A GB 1307100 A GB1307100 A GB 1307100A GB 5535570 A GB5535570 A GB 5535570A GB 5535570 A GB5535570 A GB 5535570A GB 1307100 A GB1307100 A GB 1307100A
- Authority
- GB
- United Kingdom
- Prior art keywords
- amine
- erythromycyl
- erythromycin
- oxime
- hydrogenation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001412 amines Chemical class 0.000 title abstract 5
- IDRYSCOQVVUBIJ-UHFFFAOYSA-N Erythromycin-B Natural products CC1C(OC2C(C(CC(C)O2)N(C)C)O)C(C)(O)CC(C)C(=O)C(C)C(O)C(C)C(CC)OC(=O)C(C)C1OC1CC(C)(OC)C(O)C(C)O1 IDRYSCOQVVUBIJ-UHFFFAOYSA-N 0.000 abstract 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 2
- IDRYSCOQVVUBIJ-PPGFLMPOSA-N erythromycin B Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@H]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)C)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 IDRYSCOQVVUBIJ-PPGFLMPOSA-N 0.000 abstract 2
- 238000005984 hydrogenation reaction Methods 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 150000002923 oximes Chemical class 0.000 abstract 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 abstract 1
- 241000295644 Staphylococcaceae Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 229910000510 noble metal Inorganic materials 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- 229910052703 rhodium Inorganic materials 0.000 abstract 1
- 239000010948 rhodium Substances 0.000 abstract 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 abstract 1
- 229910052707 ruthenium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87893669A | 1969-11-21 | 1969-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1307100A true GB1307100A (en) | 1973-02-14 |
Family
ID=25373117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5535570A Expired GB1307100A (en) | 1969-11-21 | 1970-11-20 | Erythromycyl b amine |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3772270A (https=) |
| AT (1) | AT300196B (https=) |
| BE (1) | BE759252A (https=) |
| CA (1) | CA936155A (https=) |
| CH (1) | CH550164A (https=) |
| DE (1) | DE2057188C3 (https=) |
| FR (1) | FR2073400B1 (https=) |
| GB (1) | GB1307100A (https=) |
| IE (1) | IE34739B1 (https=) |
| IL (1) | IL35606A (https=) |
| NL (1) | NL7016922A (https=) |
| SE (1) | SE375777B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110800A (en) * | 1986-02-18 | 1992-05-05 | Eli Lilly And Company | Derivatives of erythromycylamine |
| US4945080A (en) * | 1987-05-26 | 1990-07-31 | Eli Lilly And Company | Dirithromycin metabolite |
| US5929219A (en) | 1997-09-10 | 1999-07-27 | Abbott Laboratories | 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same |
| US20040022740A1 (en) * | 2001-07-10 | 2004-02-05 | Baker William R. | Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1100504A (en) * | 1967-08-16 | 1968-01-24 | Pliva Pharm & Chem Works | Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide |
| ZA695765B (en) * | 1968-08-29 | 1971-03-31 | Lilly Co Eli | Erythromycylamine and process for preparing same |
-
0
- BE BE759252D patent/BE759252A/xx unknown
-
1969
- 1969-11-21 US US00878936A patent/US3772270A/en not_active Expired - Lifetime
-
1970
- 1970-11-08 IL IL35606A patent/IL35606A/en unknown
- 1970-11-17 IE IE1473/70A patent/IE34739B1/xx unknown
- 1970-11-17 CA CA098318A patent/CA936155A/en not_active Expired
- 1970-11-18 SE SE7015584A patent/SE375777B/xx unknown
- 1970-11-19 NL NL7016922A patent/NL7016922A/xx unknown
- 1970-11-20 AT AT1048970A patent/AT300196B/de not_active IP Right Cessation
- 1970-11-20 CH CH1726770A patent/CH550164A/xx not_active IP Right Cessation
- 1970-11-20 DE DE2057188A patent/DE2057188C3/de not_active Expired
- 1970-11-20 FR FR7041734A patent/FR2073400B1/fr not_active Expired
- 1970-11-20 GB GB5535570A patent/GB1307100A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2057188A1 (de) | 1971-06-03 |
| DE2057188C3 (de) | 1974-05-22 |
| IE34739B1 (en) | 1975-08-06 |
| NL7016922A (https=) | 1971-05-25 |
| DE2057188B2 (de) | 1973-10-11 |
| FR2073400B1 (https=) | 1974-08-30 |
| AT300196B (de) | 1972-07-10 |
| BE759252A (fr) | 1971-05-21 |
| IE34739L (en) | 1971-05-21 |
| IL35606A0 (en) | 1971-01-28 |
| CH550164A (de) | 1974-06-14 |
| IL35606A (en) | 1973-06-29 |
| US3772270A (en) | 1973-11-13 |
| CA936155A (en) | 1973-10-30 |
| SE375777B (https=) | 1975-04-28 |
| FR2073400A1 (https=) | 1971-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scott et al. | New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species | |
| HUP0202017A2 (hu) | Új vegyületek | |
| NL7507268A (nl) | Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten. | |
| GB1307100A (en) | Erythromycyl b amine | |
| GB1284681A (en) | Improvements in or relating to 4,5,6,7-tetrahydroindazoles | |
| BG49826A3 (en) | Method for preparing derivatives of thilosine and 10, 11, 12, 13- tetrahydrothilosine | |
| GB1275473A (en) | Erythromycylamine and process for preparing same | |
| Phillips | Past and current use of clindamycin and lincomycin | |
| Mayer et al. | The effect of Pneumocystis carinii pneumonia prophylaxis regimens on the incidence of bacterial infections in HIV-infected patients | |
| GB1294733A (en) | 4-aryl-4-hydroxypiperidine derivatives and processes for the preparation thereof | |
| GB1033394A (en) | New therapeutic agents | |
| GB1474749A (en) | Pharmaceutical preparations based on cyproterone | |
| IE35379L (en) | Erythromycylamine compounds | |
| SU1019810A1 (ru) | Метиловый эфир 5(6)-[1-(2Н)-фталазинонил-4]-1Н-бензимидазолил-2-карбаминовой кислоты, обладающий антигельминтной активностью | |
| GB1230804A (https=) | ||
| FR2097045A1 (en) | 17-ethynylgon-4-en-3-ones - with progestomimetic activity useful as contraceptives and for gynaecological disorders | |
| NL7416691A (nl) | Werkwijze voor de bereiding van 17(alpha)-acyloxy-21- oxypregnanen, alsmede farmaceutische pre- en die deze verbindingen als actieve com- ten omvatten. | |
| GB1319252A (en) | 1-phenyl-alkanols and process for making same | |
| Curray et al. | Pharmacology of chlorpromazine: clinical studies | |
| IT1260467B (it) | Medicamento contenente arg-gly-asp per il trattamento del glaucoma | |
| GB1415902A (en) | Process for preparing phthalazone | |
| ATE43586T1 (de) | Arphameninderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| Simeonov | Can BCG Vaccination Induce Skin Hypersensitivity to Histoplasmin? | |
| GB954829A (en) | Therapeutic composition containing di-isopropylhydrazide of oxalic acid | |
| GB1051824A (https=) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |